Stanford University


Showing 51-60 of 76 Results

  • Jessica L. Ruiz

    Jessica L. Ruiz

    Instructor, Pediatrics - Endocrinology

    BioDr. Jessica Ruiz is a pediatric endocrinologist and Instructor at Stanford University and the Lucile Packard Children’s Hospital.

    As a pediatrician-scientist and bioengineer, Dr. Ruiz's scholarly interest is pediatric type 2 diabetes. Her passion is to better predict, prevent and treat type 2 diabetes through digital phenotyping. Dr. Ruiz's vision is to apply data science and machine learning approaches to continuous glucose monitoring (CGM) data. Her work seeks to parameterize glucose kinetics to ultimately build CGM-based type 2 diabetes risk profiles. She is also involved in multiple clinical studies using dynamic CGM metrics to inform clinical care for patients with diabetes - including staging of diabetes as it develops.

    Clinically, Dr. Ruiz enjoys caring for all pediatric patients seeking general endocrinology and diabetes care.

    A native Texan, Dr. Ruiz obtained a B.S. in Bioengineering from Rice University (Houston, TX). She completed her M.D. at Harvard Medical School in the Harvard-MIT Health Sciences and Technology (HST) program (Boston, MA). She remained at Harvard to complete her training in Pediatrics in the Boston Combined Residency Program (Boston Children's Hospital and Boston Medical Center), followed by her training in Pediatric Endocrinology at Boston Children's Hospital. She was on the faculty at Boston Children's Hospital/Harvard Medical School as an Instructor for 2 years prior to moving to Stanford.

    Dr. Ruiz also enjoys mentoring trainees and was formerly a Harvard Medical School Faculty Advisor and Associate Program Director for the Boston Children's Pediatric Endocrinology Fellowship Program.

  • David Scheinker

    David Scheinker

    Clinical Professor, Pediatrics - Endocrinology
    Clinical Professor, Medicine

    BioDavid Scheinker is the Executive Director of Systems Design and Collaborative Research at the Stanford Lucile Packard Children's Hospital. He is the Founder and Director of SURF Stanford Medicine, a group that brings together students and faculty from the university with physicians, nurses, and administrators from the hospitals. SURF has implemented and published dozens of projects demonstrating improvements to the quality and efficiency of care. His areas of focus include clinical care delivery, technical improvements to hospital operations, sensor-based and algorithm-enabled telemedicine, and the socioeconomic factors that shape healthcare cost and quality.

    Before coming to Stanford, he was a Joint Research Fellow at The MIT Sloan School of Management and Massachusetts General Hospital. He received a PhD in theoretical math from The University of California San Diego under Jim Agler. He advises Carta Healthcare, a healthcare analytics company started by former students.

  • Sejal Shah

    Sejal Shah

    Clinical Associate Professor, Pediatrics - Endocrinology

    Current Research and Scholarly InterestsMy primary research interest is evaluating whether vitamin D supplementation can positively affect consequences of the metabolic syndrome in overweight and obese adolescents. Other research interests include evaluating the efficacy and biochemical profiles of various types of estrogen replacement in adolescent females.

  • Diane Stafford

    Diane Stafford

    Clinical Professor, Pediatrics - Endocrinology

    BioDr. Stafford specializes in Pediatric Endocrinology with special interest in disorders of puberty and Prader-Willi syndrome (PWS). Her research interests include in medical education curriculum development, faculty development and endocrine dysfunction in PWS.

  • Han Sun

    Han Sun

    Postdoctoral Scholar, Genetics
    Biostatistician 2, Pediatrics - Endocrinology

    BioHan had been a postdoc with Dr. Steinmetz at the genetics department for five years, working on both cancers and heart diseases, trying to understand the mechanisms linking from variants to disease phenotypes. This led to a few very interesting findings of aberrant splicing regulation, such as splicing-mediated readthrough stabilization (SRS), one more mechanism for oncogene activation in multiple types of cancers, and tissue-specific splicing of a mitochondrial inner membrane protein, suggesting a molecular connection between deficiency in energy-supplying and dilated cardiomyopathy.

    After being a senior computational biologist with Dr. Gloyn, who has been dedicated to the research of type 2 diabetes for decades, Han switched to the field of this multifactorial metabolic disease. It did take some courage to make such a switch at his post-postdoc stage, however, Han has a consistent interest in studying PG&E, which is not pacific gas and electric nearby, but the interaction between phenotype, genotype, and environment. With years of hands-on experience in statistical modeling and the analysis of next-generation sequencing and mass spectrometry data, in addition to a good understanding of disease genetics, cancer biology, and systems biology, Han is highly confident that he will enjoy the adventure and contribute to our understanding of diabetes.